Moderna aims to deliver 1 billion more vaccine doses to low-income countries in 2022

Subscribe

imageWorld4 minutes ago (Oct 08, 2021 11:17AM ET)

(C) Reuters. FILE PHOTO: Test tubes are seen in front of a displayed Moderna logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic/Illustration

(Reuters) -Moderna Inc said on Friday it aims to deliver one billion doses of its COVID-19 vaccine to low-income countries in 2022, in addition to the doses it has already committed to the global vaccine-sharing platform COVAX.

These vaccines will be part of the 2-3 billion doses the company had forecast to produce next year.

“To date, more than 250 million people have been vaccinated globally with the Moderna (NASDAQ:MRNA) COVID-19 vaccine. However, we recognize that access to vaccines continues to be a challenge in many parts of the world,” Chief Executive Officer Stephane Bancel said in a letter https://investors.modernatx.com/news-releases/news-release-details/our-global-commitment-vaccine-access posted on the company’s website.

Moderna on Thursday announced plans to invest up to $500 million to build a factory in Africa to make up to 500 million doses of mRNA vaccines each year, including its COVID-19 shot.

The company had committed in May to supply up to 500 million doses of its COVID-19 vaccine to the COVAX facility from the fourth quarter of 2021 through 2022.

“We are committed to doubling our manufacturing and expanding supply even further until our vaccine is no longer needed in low-income countries,” Bancel said.

Moderna aims to deliver 1 billion more vaccine doses to low-income countries in 2022

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.